Supply chain assessments

Assessing the surety of the most complex Supply Chains

Creating a unique medical solution and planning for its successful roll-out in clinical trials is a complex process – particularly when the scope of implementation is international.

Eramol provides specialist advice in this area, undertaking prospective risk assessments for end-to-end supply chains. We detail key aspects of a project such as its sustainability, together with contingency planning assessments in the event of supply and distribution complications.

We can illustrate local depot or direct-to-site distribution models, factoring in local regulatory and customs requirements for each proposed territory.

Getting your medicinal supplies manufactured and distributed across the world takes time, planning and a considered budget. Eramol ensures that all factors are addressed, leaving nothing to chance in local, and international, supply chains.